Invites Biocore Co., Ltd. (XKON:A216400) agreed to acquire 85% stake in PROCAGEN from Byun Seok-soo for approximately KRW 12,748 million on July 14, 2022. PROCAGEN generated Total assets of KRW 1,101 million, Total equity of KRW 993 million and Net Income of KRW -528 million for the financial year 2021. Transaction is expected to close on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,400 KRW | -2.63% |
|
-2.50% | -20.43% |
1st Jan change | Capi. | |
---|---|---|
-20.43% | 42.44M | |
-43.34% | 7.74B | |
+10.68% | 3.66B | |
-1.60% | 2.24B | |
-22.96% | 1.98B | |
-22.17% | 1.64B | |
+5.19% | 915M | |
+17.25% | 733M | |
-6.99% | 710M | |
-37.14% | 454M |
- Stock Market
- Equities
- A216400 Stock
- News Invites Biocore Co., Ltd.
- Invites Biocore Co., Ltd. agreed to acquire 85% stake in PROCAGEN from Byun Seok-soo.